BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Phạm TL, Kim DW. Poly(lactic-co-glycolic acid) nanomaterial-based treatment options for pain management: a review. Nanomedicine (Lond) 2020. [PMID: 32757701 DOI: 10.2217/nnm-2020-0114] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Tran Q, Pham TL, Shin HJ, Shin J, Shin N, Kwon HH, Park H, Kim SI, Choi SG, Wu J, Ngo VT, Park JB, Kim DW. Targeting spinal microglia with fexofenadine-loaded nanoparticles prolongs pain relief in a rat model of neuropathic pain. Nanomedicine: Nanotechnology, Biology and Medicine 2022;44:102576. [DOI: 10.1016/j.nano.2022.102576] [Reference Citation Analysis]
2 Jiang M, Wang Y, Wang J, Feng S, Wang X. The etiological roles of miRNAs, lncRNAs, and circRNAs in neuropathic pain: A narrative review. J Clin Lab Anal 2022;:e24592. [PMID: 35808924 DOI: 10.1002/jcla.24592] [Reference Citation Analysis]
3 Neto E, Monteiro AC, Leite Pereira C, Simões M, Conde JP, Chu V, Sarmento B, Lamghari M. Micropathological Chip Modeling the Neurovascular Unit Response to Inflammatory Bone Condition. Adv Healthc Mater 2022;11:e2102305. [PMID: 35158409 DOI: 10.1002/adhm.202102305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Pardeshi SR, Nikam A, Chandak P, Mandale V, Naik JB, Giram PS. Recent advances in PLGA based nanocarriers for drug delivery system: a state of the art review. International Journal of Polymeric Materials and Polymeric Biomaterials. [DOI: 10.1080/00914037.2021.1985495] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Kim SI, Shin J, Tran Q, Park H, Kwon HH, Shin N, Hwang JA, Shin HJ, Lee J, Lee WH, Lee SY, Kim DW. Application of PLGA nanoparticles to enhance the action of duloxetine on microglia in neuropathic pain. Biomater Sci 2021. [PMID: 34378557 DOI: 10.1039/d1bm00486g] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
6 Lee S, Shin HJ, Noh C, Kim SI, Ko YK, Lee SY, Lim C, Hong B, Yang SY, Kim DW, Lee WH, Kim YH. IKBKB siRNA-Encapsulated Poly (Lactic-co-Glycolic Acid) Nanoparticles Diminish Neuropathic Pain by Inhibiting Microglial Activation. Int J Mol Sci 2021;22:5657. [PMID: 34073390 DOI: 10.3390/ijms22115657] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Miralles-Cardiel E, Silva-Abreu M, Calpena AC, Casals I. Development and Validation of an HPLC-MS/MS Method for Pioglitazone from Nanocarriers Quantitation in Ex Vivo and In Vivo Ocular Tissues. Pharmaceutics 2021;13:650. [PMID: 34063615 DOI: 10.3390/pharmaceutics13050650] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
8 Zheng M, Jia H, Wang H, Liu L, He Z, Zhang Z, Yang W, Gao L, Gao X, Gao F. Application of nanomaterials in the treatment of rheumatoid arthritis. RSC Adv 2021;11:7129-37. [DOI: 10.1039/d1ra00328c] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
9 Garms BC, Poli H, Baggley D, Han FY, Whittaker AK, A A, Grøndahl L. Evaluating the effect of synthesis, isolation, and characterisation variables on reported particle size and dispersity of drug loaded PLGA nanoparticles. Mater Adv 2021;2:5657-71. [DOI: 10.1039/d1ma00410g] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]